---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-098326"
form_type: "8-K"
ticker: "TBPH"
cik: "0001583107"
company_name: "Theravance Biopharma, Inc."
filed_at: "2024-09-10T23:59:59+00:00"
generated_at: "2026-05-31T05:38:59.271604+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "low"
source: SEC EDGAR
---

# Theravance Biopharma presents at H.C. Wainwright conference; no material financial updates in slide deck

## Summary
- Management team to participate in fireside chat and one-on-one meetings at H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024.
- Slide presentation furnished as Exhibit 99.1 contains no new financial guidance or operational data beyond prior disclosures.
- Filing is a procedural Regulation FD disclosure for investor presentation; no earnings, M&A, or leadership changes announced.

## SEC filing metadata
- accession: 0001104659-24-098326
- form_type: 8-K
- ticker: TBPH
- cik: 0001583107
- company_name: Theravance Biopharma, Inc.
- filed_at: 2024-09-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583107/000110465924098326/0001104659-24-098326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583107/000110465924098326/tm2423596d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-098326
- JSON: https://secwatch.observer/filing/0001104659-24-098326.json
- Plain text: https://secwatch.observer/filing/0001104659-24-098326.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.